SCHEMBL697205

SCHEMBL697205

Cc1cccc([C@H](C)c2nccn2Cc2ccc(Cl)cc2)c1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
KCNH2 Q12809 3/20 0.43
BRD4 O60885 1/20 0.42
CYP2D6 P10635 3/20 0.41
CYP2C19 P33261 3/20 0.41
CYP1A2 P05177 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX12 P18054 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
TSHR P16473 1/20 0.38
HIF1A Q16665 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703762 0.91 TDP1 (0.44) TDP1KCNH2CYP2D6CYP2C19CYP1A2
SCHEMBL696289 0.90 TDP1 (0.54) TDP1KCNH2BRD4CYP2D6CYP2C19
SCHEMBL695900 0.90 TDP1 (0.54) TDP1KCNH2BRD4CYP2D6CYP2C19
SCHEMBL697336 0.89 BRD4 (0.49) TDP1KCNH2BRD4CYP2D6CYP2C19
SCHEMBL697990 0.89 TDP1 (0.46) TDP1KCNH2CYP2D6CYP2C19CYP1A2
SCHEMBL698831 0.89 TDP1 (0.43) TDP1KCNH2CYP2D6CYP2C19CYP1A2
SCHEMBL698832 0.89 TDP1 (0.44) TDP1KCNH2CYP2D6CYP2C19CYP1A2
SCHEMBL697360 0.88 FSCN1 (0.44) TDP1KCNH2BRD4LMNAL3MBTL1
SCHEMBL697359 0.88 TDP1 (0.47) TDP1BRD4CYP2D6CYP2C19CYP1A2
SCHEMBL10790632 0.88 TDP1 (0.56) TDP1KCNH2BRD4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 TDP1 2820/4885KCNH2 277/4885BRD4 85/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 TDP1 2820/4885KCNH2 277/4885BRD4 85/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.